The Board and Executive Team at XVIVO is responsible for setting the strategic direction, overseeing company operations, ensuring regulatory compliance, and making key decisions to drive innovation in organ, tissue, and cell preservation technologies. They provide leadership, governance, and alignment across the organization to achieve corporate goals and enhance patient outcomes in transplantation.